Literature DB >> 31696978

The sirtuin 6: An overture in skin cancer.

Liz M Garcia-Peterson1, Glorimar Guzmán-Pérez1, Cassandre R Krier1, Nihal Ahmad1,2.   

Abstract

In the recent past, the sirtuins have been under intense investigation for their roles in biology and disease, including cancer. The sirtuin SIRT6 is comparatively a lesser studied member of this family of seven proteins. Like certain other sirtuins, SIRT6 is emerging to have an oncogenic function as well as tumor suppressor roles in cancer. Limited studies have been conducted assessing the role and functional significance of SIRT6 in melanoma and non-melanoma skin cancers. In this review, we have attempted to critically dissect the potential role and significance of SIRT6 in skin carcinogenesis. With limited available information to date, SIRT6 appears to have a pro-proliferative function in non-melanoma skin cancers (NMSCs), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). In addition, SIRT6 is also emerging to have an oncogenic function in melanoma. Moreover, we have provided information regarding the available SIRT6 inhibitors. Conclusively, it appears that additional comprehensive studies are needed to establish the role of SIRT6 in skin biology and skin diseases, including cancer. Further, concerted efforts are needed to characterize the stage-specific role of SIRT6 in skin cancers.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SIRT6; melanoma; skin; skin cancer

Mesh:

Substances:

Year:  2019        PMID: 31696978      PMCID: PMC8205187          DOI: 10.1111/exd.14057

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  74 in total

1.  Discovery of novel and selective SIRT6 inhibitors.

Authors:  Marco Daniele Parenti; Alessia Grozio; Inga Bauer; Lauretta Galeno; Patrizia Damonte; Enrico Millo; Giovanna Sociali; Claudio Franceschi; Alberto Ballestrero; Santina Bruzzone; Alberto Del Rio; Alessio Nencioni
Journal:  J Med Chem       Date:  2014-05-19       Impact factor: 7.446

Review 2.  Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Authors:  Ross L Pearlman; Mary Katherine Montes de Oca; Harish Chandra Pal; Farrukh Afaq
Journal:  Cancer Lett       Date:  2017-01-25       Impact factor: 8.679

3.  SIRT6 promotes DNA repair under stress by activating PARP1.

Authors:  Zhiyong Mao; Christopher Hine; Xiao Tian; Michael Van Meter; Matthew Au; Amita Vaidya; Andrei Seluanov; Vera Gorbunova
Journal:  Science       Date:  2011-06-17       Impact factor: 47.728

4.  SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.

Authors:  Long-Kuan Ran; Yong Chen; Zhen-Zhen Zhang; Na-Na Tao; Ji-Hua Ren; Li Zhou; Hua Tang; Xiang Chen; Ke Chen; Wan-Yu Li; Ai-Long Huang; Juan Chen
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

Review 5.  Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction.

Authors:  Marcia C Haigis; Leonard P Guarente
Journal:  Genes Dev       Date:  2006-11-01       Impact factor: 11.361

Review 6.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

7.  SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span.

Authors:  Tiara L A Kawahara; Eriko Michishita; Adam S Adler; Mara Damian; Elisabeth Berber; Meihong Lin; Ron A McCord; Kristine C L Ongaigui; Lisa D Boxer; Howard Y Chang; Katrin F Chua
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

8.  Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.

Authors:  Antonia Cagnetta; Debora Soncini; Stefania Orecchioni; Giovanna Talarico; Paola Minetto; Fabio Guolo; Veronica Retali; Nicoletta Colombo; Enrico Carminati; Marino Clavio; Maurizio Miglino; Micaela Bergamaschi; Aimable Nahimana; Michel Duchosal; Katia Todoerti; Antonino Neri; Mario Passalacqua; Santina Bruzzone; Alessio Nencioni; Francesco Bertolini; Marco Gobbi; Roberto M Lemoli; Michele Cea
Journal:  Haematologica       Date:  2017-10-12       Impact factor: 9.941

9.  SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence.

Authors:  Luisa Tasselli; Yuanxin Xi; Wei Zheng; Ruth I Tennen; Zaneta Odrowaz; Federica Simeoni; Wei Li; Katrin F Chua
Journal:  Nat Struct Mol Biol       Date:  2016-04-04       Impact factor: 15.369

10.  SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.

Authors:  Thomas Strub; Flavia G Ghiraldini; Saul Carcamo; Man Li; Aleksandra Wroblewska; Rajendra Singh; Matthew S Goldberg; Dan Hasson; Zichen Wang; Stuart J Gallagher; Peter Hersey; Avi Ma'ayan; Georgina V Long; Richard A Scolyer; Brian Brown; Bin Zheng; Emily Bernstein
Journal:  Nat Commun       Date:  2018-08-24       Impact factor: 14.919

View more
  7 in total

Review 1.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

2.  Skin epigenetics.

Authors:  Bogi Andersen; Sarah Millar
Journal:  Exp Dermatol       Date:  2021-07-05       Impact factor: 4.511

3.  Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors.

Authors:  Nina Schmid; Kim-Gwendolyn Dietrich; Ignasi Forne; Alexander Burges; Magdalena Szymanska; Rina Meidan; Doris Mayr; Artur Mayerhofer
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

Review 4.  Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review.

Authors:  Huang-Yu Yang; Chao-Yi Wu; Jia-Jin Chen; Tao-Han Lee
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 5.  Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review.

Authors:  Xiaojing Wu; Shuyuan Wang; Xuanzhu Zhao; Sizhen Lai; Zhen Yuan; Yixiang Zhan; Kemin Ni; Zhaoce Liu; Lina Liu; Ran Xin; Xingyu Zhou; Xin Yin; Xinyu Liu; Xipeng Zhang; Wei Cui; Chunze Zhang
Journal:  Cancer Cell Int       Date:  2022-02-16       Impact factor: 5.722

6.  Structural Insight into the Interactions between Structurally Similar Inhibitors and SIRT6.

Authors:  Shuang Zhao; Yan-Yan Zhu; Xiao-Yu Wang; Yong-Sheng Liu; Yun-Xiang Sun; Qing-Jie Zhao; Hui-Yu Li
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

7.  A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.

Authors:  Yi Ding; Tian Li; Min Li; Tuersong Tayier; MeiLin Zhang; Long Chen; ShuMei Feng
Journal:  Biomed Res Int       Date:  2021-06-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.